company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1490000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1755000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13529000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20914000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20914000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-368000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11527000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31711000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19816000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19816000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-68000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1519000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,93000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1544000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1544000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,446000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q1,2010-07-01,2010-09-30,2011-11-03 17:26:52+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2349000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1454000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2184000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3250000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12054000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12054000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-755000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17896000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36801000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-82000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1487000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1398000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8899000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q2,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2373000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11500000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1422000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5765000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16891000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-196000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38965000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-74000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1604000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1530000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1530000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q3,2011-01-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2372000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21752000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21752000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3250000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6377000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2396000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2061000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11790000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11790000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-582000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21946000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21292000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21292000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-57000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2941000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1491000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1243000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1243000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10745000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2011.0,Q4,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2011000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1334000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1051000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14722000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13527000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13527000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-433000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4801000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15937000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,38000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,38000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24268000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,2011-07-01,2011-09-30,2012-10-30 12:51:12+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3806000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3806000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1296000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4468000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21636000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19678000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19678000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-493000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-139000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4615000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3983000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3983000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-280000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8171000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3691000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3691000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12004000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1735000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1235000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13335000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36242000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,379000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36035000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36035000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-3702000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59816000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56114000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56114000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2662000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,2012-01-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1731000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8027000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8027000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1211000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4643000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4843000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9978000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9978000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-339000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10157000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2628000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2628000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,274000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7226000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q4,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1731000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1146000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1029000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11626000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21370000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21370000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-804000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12416000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27484000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14264000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14264000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,361000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,361000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,361000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6745000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,2012-07-01,2012-09-30,2013-11-01 16:20:38+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1735000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10930000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10930000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1132000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1129000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3685000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24409000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-29393000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-29393000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-660000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49606000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18166000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-32100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-32100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-4644000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,76648000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,72004000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,72004000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10511000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1728000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1072000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1108000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1374000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4182000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22221000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22221000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-547000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11425000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18704000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6732000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6732000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-78000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-78000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15567000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,2013-01-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1726000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17651000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17651000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1000000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1210000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,12777000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11419000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14083000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14083000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-329000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37276000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32347000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5258000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5258000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-96750000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,132250000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,581000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36079000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36079000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16738000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q4,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1375000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1103000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1269000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2757000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14953000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1112000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1112000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-198000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18760000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10846000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10846000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-95000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-470000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16832000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,16267000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,16267000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,2013-07-01,2013-09-30,2014-11-05 16:17:15+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16408000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1250000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1306000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2045000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-21396000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33203000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33203000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-527000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38786000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,9000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-443000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30748000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30314000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30314000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2003000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24932000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1223000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1324000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1752000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5504000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15129000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15129000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-640000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12263000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14248000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14248000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-127000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5992000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5865000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5865000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4984000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,2014-01-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,119000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,930000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1359000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3255000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,455000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22238000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22238000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1249000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15145000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30436000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14042000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14042000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-512000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25121000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24609000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24609000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16413000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q4,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2103000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,876000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1396000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4838000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18769000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18769000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-483000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28272000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3038000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3038000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,50000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21762000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,2014-07-01,2014-09-30,2015-11-05 18:19:02+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,121000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,929000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1431000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5715000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1986000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1986000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1237000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35422000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24709000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11950000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11950000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-614000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31894000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31280000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31280000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21316000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2102000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58307000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,971000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1468000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-25350000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2859000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38255000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38255000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-354000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30726000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58628000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27548000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27548000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-108000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7630000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73325000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,2015-01-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,119000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,473000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1543000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2016000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2249000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-411000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41331000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60949000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19207000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19207000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,664000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,664000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,664000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,667000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,2015-07-01,2015-09-30,2016-11-03 08:36:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,121000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,386000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1563000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42257000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42257000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1092000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73628000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4138000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4138000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4138000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,895000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2103000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,419000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1613000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4546000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14930000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1167000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1167000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1223000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27115000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34568000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6230000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6230000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,142000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,142000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,142000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5205000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,2016-01-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,128000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,577000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1961000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11528000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5884000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18044000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18044000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-104468000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59746000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15819000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,263090000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,247271000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,247271000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,169481000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,2017-07-01,2017-09-30,2018-10-30 08:08:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,89000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-52448000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-52448000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23819000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28629000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28629000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47233000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,114556000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,67213000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,67213000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-192000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2501000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40893000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1766000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q4,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,533000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1441000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7188000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-19216000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34865000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-265000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-87308000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,101279000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,35000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13741000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13741000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15000000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-369000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,33776000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18411000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,36818000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,36818000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15759000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,2018-07-01,2018-09-30,2018-10-30 08:08:34+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,537000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1591000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6144000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14766000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43988000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43988000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-612000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-156047000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,105017000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51642000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51642000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-655000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45827000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50458000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,2019-01-01,2019-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,437000.0
